BEVATAS

BEVATAS

Manufacturer:

Intas
Basic Prescribing Info
Contents
bevacizumab.
ATC Classification
L01XC07 - bevacizumab ; Belongs to the class of monoclonal antibodies, other antineoplastic agents. Used in the treatment of cancer.
Presentation/Packing
Form
BEVATAS inj
Packing/Price
100 mg x 4ml (9,500 INR);400 mg x 16ml (36,061.64 INR)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in